Patient selection and preparation strategies for the use of contrast material in patients with chronic kidney disease
Open Access
- 1 January 2012
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Radiology
- Vol. 4 (6) , 253-7
Abstract
The prevalence of chronic kidney disease and peripheral arterial disease is increasing. Thus, it is increasingly problematic to image these patients as the number of patients needing a vascular examination is increasing accordingly. In high-risk patients with impaired kidney function, intravascular administration of iodinated contrast media can result in contrast-induced acute kidney injury and Gadolinium can induce nephrogenic systemic fibrosis (NSF). It is important to identify these high-risk patients by means of se-creatinine/e glomerular filtration rate. The indication for contrast examination should counterbalance the increased risk. One or more alternative examination methods without contrast media, such as CO(2) angiography, Ultrasound/Doppler examination or magnetic resonance angiography without contrast should be considered, but at the same time, allow for a meaningful outcome of the examination. If contrast is deemed essential, the patient should be well hydrated, the amount of contrast should be restricted, the examination should be focused, metformin and diuretics stopped, and renal function monitored. Sodium bicarbonate and N-acetylcysteine are popular but their efficiency is not evidence-based. There is no evidence that dialysis protects patients with impaired renal function from contrast-induced nephropathy or NSF.Keywords
This publication has 17 references indexed in Scilit:
- B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary interventionActa Radiologica, 2010
- Nephrogenic systemic fibrosis and contrast medium-induced nephropathy: a choice between the devil and the deep blue sea for patients with reduced renal function?Acta Radiologica, 2009
- Gadolinium-associated nephrogenic systemic fibrosis.2009
- Nephrogenic Systemic Fibrosis after Gadopentetate Dimeglumine Exposure: Case Series of 36 PatientsRadiology, 2009
- Prevention of Contrast-Induced Nephropathy: An OverviewRadiologic Clinics of North America, 2009
- Nephrogenic Systemic FibrosisJournal of the American Society of Nephrology, 2006
- Peripheral Arterial Disease in Patients With DiabetesJACC, 2006
- Prevalence of and Risk Factors for Peripheral Arterial Disease in the United StatesCirculation, 2004
- Prevalence of Lower-Extremity Disease in the U.S. Adult Population ≥40 Years of Age With and Without DiabetesDiabetes Care, 2004
- Prevalence of advanced renal failure in Northern Ireland.BMJ, 1990